Latest Conference Coverage


Cladribine Shows Durable Efficacy in Relapsing Multiple Sclerosis

Cladribine Shows Durable Efficacy in Relapsing Multiple Sclerosis

February 29th 2020

Data from the CLARITY extension trial suggest that the durability of treatment with cladribine extended beyond 24 months in those with relapsing-remitting multiple sclerosis.


Incomplete Recovery From MS Relapse May Contribute to Long-Term Disability

Incomplete Recovery From MS Relapse May Contribute to Long-Term Disability

February 29th 2020

Recovery status may be a useful tool to predict long-term outcomes in patients with relapsing forms of multiple sclerosis.


Earlier Ocrelizumab Treatment in MS Has Positive Long-term Impact

Earlier Ocrelizumab Treatment in MS Has Positive Long-term Impact

February 28th 2020

Compared with patients who initially received interferon treatment, those given ocrelizumab had superior disability progression after a 6-year follow-up.


Siponimod Significantly Slows MS Disability Progression in Patients With Shorter Disease Duration

Siponimod Significantly Slows MS Disability Progression in Patients With Shorter Disease Duration

February 27th 2020

Patients with a disease duration of <16 years demonstrated a significantly greater reduction in risk for confirmed disability progression (CDP) at 3 and 6 months.


Early Administration of Tranexamic Acid May Reduce Intracerebral Hemorrhage in Stroke

Early Administration of Tranexamic Acid May Reduce Intracerebral Hemorrhage in Stroke

February 26th 2020

Phase 2 STOP-AUST data suggest that the antifibrinolytic agent may be able to reduce ICH in spot sign positive patients with stroke when administered within 2 to 3 hours of onset, warranting further study.


Low-Dose Tenecteplase Ideal for Stroke Treatment

Low-Dose Tenecteplase Ideal for Stroke Treatment

February 25th 2020

New study data from ISC 2020 suggest that patients with stroke can be effectively treated with tenecteplase at a lower dose of 0.25 mg/kg, reducing the need for mechanical clot removal.


Functional Outcomes Improved by Mobile Stroke Units

Functional Outcomes Improved by Mobile Stroke Units

February 24th 2020

Stroke patients experienced higher rates of thrombolysis as well as faster alarm to treatment times when mobile stroke units were present.


Lower LDL-C Target May Help Prevent Vascular Events Following Ischemic Stroke

Lower LDL-C Target May Help Prevent Vascular Events Following Ischemic Stroke

February 24th 2020

The composite primary end point of the study occurred in 9.6% of patients in the lower-target LDL-C group compared with 12.9% in the higher target group.


Novel Stroke Treatment Nerinetide Falls Short in Phase 3

Novel Stroke Treatment Nerinetide Falls Short in Phase 3

February 22nd 2020

Despite missing the primary end point, data from a subset of patients suggest that the novel peptide may be beneficial in those who have not received alteplase.


Portable MRI Safe and Functional for Bedside Stroke Imaging

Portable MRI Safe and Functional for Bedside Stroke Imaging

February 21st 2020

Despite the conventional need for patients to travel to MRI devices, the use of a point-of-care, portable scanner has proven to be a feasible method of acquiring clinically useful images.


Shingles Vaccine Linked to Lower Risk of Stroke

Shingles Vaccine Linked to Lower Risk of Stroke

February 20th 2020

The beneficial impact on stroke risk appeared to be greater in patients age 79 and younger than in the older patients examined.


Risk Score May Help Identify Migraine Patients At Risk for Stroke

Risk Score May Help Identify Migraine Patients At Risk for Stroke

February 20th 2020

The model may help clinicians enact preventative measures for those with migraine with aura at an early stage.


Lara Jehi, MD: Weighing Cognitive Risks in Epilepsy Surgery

Lara Jehi, MD: Weighing Cognitive Risks in Epilepsy Surgery

February 12th 2020

The professor of neurology and epilepsy specialist at the Cleveland Clinic Lerner College of Medicine discussed the difficult treatment decisions faced when undergoing epilepsy surgery.


Zachary Grinspan, MD, MS: Collaborating Across Specialties to Improve Outcomes

Zachary Grinspan, MD, MS: Collaborating Across Specialties to Improve Outcomes

February 6th 2020

The director of the Pediatric Epilepsy Program and an MD candidate at Weill Cornell Medicine detail the steps needed to take to improve outcomes in status epilepticus.


The Evolution of Epilepsy Care: Where We Are Going

The Evolution of Epilepsy Care: Where We Are Going

January 30th 2020

Page B. Pennell, MD, president of the American Epilepsy Society, shared her thoughts on the epilepsy treatment landscape, managing women with epilepsy, and the need for multidisciplinary involvement and communication.


Page B. Pennell, MD: Improving Epilepsy Care in 2020 and Beyond

Page B. Pennell, MD: Improving Epilepsy Care in 2020 and Beyond

January 28th 2020

The president of the American Epilepsy Society and director of epilepsy research at Brigham and Women’s Hospital outlined the state of epilepsy care and what we can expect in 2020.


Zachary Grinspan, MD, MS: Improving Adherence to Status Epilepticus Protocols

Zachary Grinspan, MD, MS: Improving Adherence to Status Epilepticus Protocols

January 28th 2020

The director of the Pediatric Epilepsy Program is joined by an MD candidate from Weill Cornell Medicine to discuss the protocol used to treat patients with status epilepticus.


Erin Conrad, MD: Identifying the Seizure Onset Zone

Erin Conrad, MD: Identifying the Seizure Onset Zone

January 24th 2020

The epilepsy fellow at the hospital of the University of Pennsylvania detailed why locating the seizure onset zone plays a crucial role in successful epilepsy surgery.


Elizabeth Gerard, MD: Explaining the Breastfeeding Gap In Epilepsy

Elizabeth Gerard, MD: Explaining the Breastfeeding Gap In Epilepsy

January 23rd 2020

The associate professor of neurology and director of the Women With Epilepsy Program at Northwestern University Feinberg School of Medicine detailed the ongoing questions about assessing the gaps in breastfeeding between women with, and without, epilepsy.


Elizabeth Gerard, MD: Successful Breastfeeding in Women With Epilepsy

Elizabeth Gerard, MD: Successful Breastfeeding in Women With Epilepsy

January 22nd 2020

The associate professor of neurology and director of the Women With Epilepsy Program at Northwestern University Feinberg School of Medicine spoke about the findings of the MONEAD study and their implications for women with epilepsy.


The Potential of Gene Therapy to Treat SCN1A-Positive Epilepsy

The Potential of Gene Therapy to Treat SCN1A-Positive Epilepsy

January 22nd 2020

The medical director of the Comprehensive Epilepsy Clinic at Nicklaus Children’s Hospital shared his insight into the potential of using an SCN1A-targeted adeno-associated viral vector-based gene therapy in epilepsy.


Elizabeth Gerard, MD: Advising Women With Epilepsy to Breastfeed

Elizabeth Gerard, MD: Advising Women With Epilepsy to Breastfeed

January 21st 2020

The associate professor of neurology and director of the Women With Epilepsy Program at Northwestern University Feinberg School of Medicine spoke about the need for consistency in the messaging conveyed to women with epilepsy who are having children.


Lara Jehi, MD: Risks of Epilepsy Surgery

Lara Jehi, MD: Risks of Epilepsy Surgery

January 20th 2020

The professor of neurology and epilepsy specialist at the Cleveland Clinic Lerner College of Medicine explains the decision-making process surrounding epilepsy surgery.


Opting for Epilepsy Surgery: How a Risk Assessment Tool Can Help Provide Expectations

Opting for Epilepsy Surgery: How a Risk Assessment Tool Can Help Provide Expectations

January 17th 2020

Lara Jehi, MD, professor of neurology and an epilepsy specialist at the Cleveland Clinic Lerner College of Medicine, detailed the process and decisions that patients with epilepsy face when considering surgery.


Elizabeth Felton, MD, PhD: The Utility of Transition Clinics in Epilepsy

Elizabeth Felton, MD, PhD: The Utility of Transition Clinics in Epilepsy

January 17th 2020

The assistant professor of neurology at the University of Wisconsin detailed the importance of transition clinics for pediatric patients with epilepsy.


Tapping Into Individualized Risk Prediction in Epilepsy Surgery Candidates

Tapping Into Individualized Risk Prediction in Epilepsy Surgery Candidates

January 15th 2020

Lara Jehi, MD, professor of neurology and an epilepsy specialist at the Cleveland Clinic Lerner College of Medicine, spoke to her work on individualized risk assessments for epilepsy surgery candidates and the impact it can have for both physicians and patients alike.


Elizabeth Gerard, MD: The MONEAD Study Findings

Elizabeth Gerard, MD: The MONEAD Study Findings

January 13th 2020

The associate professor of neurology and director of the Women With Epilepsy Program at Northwestern University Feinberg School of Medicine discussed the rates of breastfeeding among women with epilepsy.


Jacqueline French, MD: Safety of Intranasal Diazepam As Rescue Medication

Jacqueline French, MD: Safety of Intranasal Diazepam As Rescue Medication

January 12th 2020

The professor of neurology at NYU Langone Medical Center discussed the importance of these safety data for intranasal diazepam, and why future comparative data would be essential.

© 2024 MJH Life Sciences

All rights reserved.